Oncternal Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Oncternal Therapeutics, Inc.
CIK #0001600987, 0001260990
EDGAR Form CIK 2011 - 2025
10-K [0001260990]
10-Q [0001260990]
3 [0001260990]
4 [0001260990]
5 [0001260990]
8-K [0001260990]
D [0001260990]
SC 13D [0001260990]
SC 13G [0001260990]
D [0001600987]
SC 13G [0001600987]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Group Inc Oncternal Oncology Inc [2023-02-09]
BlackRock Inc Oncternal Therapeutics Inc [2022-07-08]
BlackRock Inc Oncternal Therapeutics Inc [2022-02-04]
CVI Investments Inc Oncternal Therapeutics Inc [2020-12-18]
Armistice Capital LLC Oncternal Therapeutics Inc [2020-05-29]
Shanghai Pharmaceutical USA Inc Oncternal Therapeutics Inc [2019-06-17]
Perceptive Advisors LLC GTX Inc /DE/ [2018-05-29]
Boxer Capital LLC GTX Inc /DE/ [2018-02-20]
Amzak Health Investors LLC GTX Inc /DE/ [2017-10-10]
Aisling Capital IV LP GTX Inc /DE/ [2017-10-05]
Formanek Investment Trust GTX Inc /DE/ [2015-04-13]
Pyramid Peak Foundation GTX Inc /DE/ [2014-11-24]
Biotechnology Value Fund L P GTX Inc /DE/ [2014-11-24]
Pyramid Peak Foundation GTX Inc /DE/ [2014-03-17]
Form 3/4/5 Subject 2011 - 2025
Oncternal Therapeutics, Inc.
Hale David F
Carter Michael G
Wills Robert James
Larue William R
Mazanet Rosemary
Theuer Charles
DeSimone Jill
Kisner Daniel L
Krishnan Rajesh
View All
Terms | Privacy | Guide
tony@aum13f.com